Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Other Operating Expenses (2016 - 2024)

Perspective Therapeutics' Other Operating Expenses history spans 15 years, with the latest figure at -$27000.0 for Q4 2024.

  • For Q4 2024, Other Operating Expenses changed N/A year-over-year to -$27000.0; the TTM value through Sep 2025 reached -$27000.0, changed N/A, while the annual FY2024 figure was -$27000.0, N/A changed from the prior year.
  • Other Operating Expenses for Q4 2024 was -$27000.0 at Perspective Therapeutics, down from $59000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $17.4 million in Q3 2023 and bottomed at -$26.8 million in Q2 2022.
  • The 5-year median for Other Operating Expenses is $28500.0 (2021), against an average of -$413500.0.
  • The largest annual shift saw Other Operating Expenses skyrocketed 80400.0% in 2020 before it plummeted 2474.0% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at -$7000.0 in 2020, then skyrocketed by 10971.43% to $761000.0 in 2021, then plummeted by 140.08% to -$305000.0 in 2022, then soared by 5793.44% to $17.4 million in 2023, then crashed by 100.16% to -$27000.0 in 2024.
  • Per Business Quant, the three most recent readings for CATX's Other Operating Expenses are -$27000.0 (Q4 2024), $59000.0 (Q3 2024), and -$59000.0 (Q2 2024).